Imidazo(2,1-b)quinazolin-5(1OH)-ones
    1.
    发明授权
    Imidazo(2,1-b)quinazolin-5(1OH)-ones 失效
    咪唑并(2,1-b)喹唑啉-5(10H) - 酮

    公开(公告)号:US3875161A

    公开(公告)日:1975-04-01

    申请号:US33156173

    申请日:1973-02-12

    Applicant: SANDOZ AG

    CPC classification number: C07D487/04 Y10S514/826

    Abstract: The compounds are of the class of imidazo(2,1-b)quinazolin5(1OH)-ones, useful, for example, as bronchodilator agents. The compounds are prepared by dehydrogenation of the corresponding 2,3-dihydro-imidazo(2,1-b)quinazolin-5(1OH)-ones.

    Abstract translation: 这些化合物是咪唑并[2,1-b]喹唑啉-5(10H)酮类,可用于例如支气管扩张剂。 通过相应的2,3-二氢 - 咪唑并[2,1-b]喹唑啉-5(1OH)酮的脱氢制备化合物。

    4-Amino-5-fluoro-2-tri(lower alkyl) silyloxypyrimidines
    2.
    发明授权
    4-Amino-5-fluoro-2-tri(lower alkyl) silyloxypyrimidines 失效
    4-氨基-5-氟-2-三(低级烷基)硅氧基嘧啶

    公开(公告)号:US3868373A

    公开(公告)日:1975-02-25

    申请号:US31746772

    申请日:1972-12-21

    Inventor: HOFFER MAX

    CPC classification number: C07H13/08 C07F7/1804 C07H19/06

    Abstract: 4-Amino-5-fluoro-2-triloweralkylsilyloxypyrimidines, useful as an intermediate in the production of antibacterial and antiviral, 1- Beta -D-arabinofuranosyl-5-fluorocytosine from fluorocytosine.

    Abstract translation: 4-氨基-5-氟-2-三氟烷基甲硅烷氧基嘧啶,可用作生产抗细菌和抗病毒药物的中间体,来自氟胞嘧啶的1-β-D-阿拉伯呋喃糖基-5-氟胞嘧啶。

    5-amino-2,6-substituted-7h-pyrrolo(2,3-d)pyrimidines and related compounds
    3.
    发明授权
    5-amino-2,6-substituted-7h-pyrrolo(2,3-d)pyrimidines and related compounds 失效
    5-氨基-2,6-取代-7H-吡咯烷(2,3-D)嘧啶和相关化合物

    公开(公告)号:US3867386A

    公开(公告)日:1975-02-18

    申请号:US37663573

    申请日:1973-07-05

    CPC classification number: C07D487/04

    Abstract: The disclosure is directed to 5-amino-2,6-substituted-7Hpyrrolo(2,3-d)pyrimidines and related compounds and to 4-halo-5pyrimidinecarbonitriles and their derivatives. The compounds have central nervous system activity as depressants. That is, they produce a calming effect in the host.

    Abstract translation: 本公开涉及5-氨基-2,6-取代的-7H-吡咯并[2,3-d]嘧啶及其相关化合物和4-卤代-5-嘧啶碳腈及其衍生物。 该化合物具有作为抑制剂的中枢神经系统活性。 也就是说,它们在主机中产生平静的效果。

    3-substituted pyrimido(4,5-b)indoles
    4.
    发明授权
    3-substituted pyrimido(4,5-b)indoles 失效
    3-取代的吡咯(4,5-B)吲哚

    公开(公告)号:US3847920A

    公开(公告)日:1974-11-12

    申请号:US36136573

    申请日:1973-05-17

    CPC classification number: C07D487/04 C07D209/40 Y10S514/927

    Abstract: 1. A MEMBER SELECTED FROM THE GROUP CONSISTING OF COMPOUNDS OF THE FORMULAS:

    3-R-PYRIMIDO(4,5-B)INDOLIUM X(-) OR 3-R-3,4-DIHYDRO-

    PYRIMIDO(4,5-B)INDOLE

    WHEREIN R IS A MEMBER SELECTED FROM THE GROUP CONSISTING OF ALKYL, DIALKYLAMINOALKYL, MONOHYDROXYALKYL IN WHICH ALKYL HAS 1 TO 7 CARBON ATOMS, PHENYL, ALKYLPHENYL HAVING A TOTAL OF 7 TO 10 CARBON ATOMS, N-OXIDE, CARBOXYMETHYL, CARBOXYMETHYL ANION, AND X IS CHLORO OR BROMO OR NONEXISTENT IN THE CASE OF ZWITTERIONS.

    Method for preparing 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine
    6.
    发明授权
    Method for preparing 2,4-diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine 失效
    制备2,4-二氨基-5-(3,4,5-三甲氧基苯基)吡嗪的方法

    公开(公告)号:US3819629A

    公开(公告)日:1974-06-25

    申请号:US16982871

    申请日:1971-08-06

    Inventor: ROTH B STRELITZ J

    CPC classification number: C07D239/49

    Abstract: THE METHOD OF PREPARING A COMPOUND I

    2,4-DI(NH2-),5-((3,5-DI(CH3-O-),4-HO-PHENYL)-CH2-)-

    PYRIMIDINE

    WHREIN R IS AN ALKYL GROUP, OR AN UNSATURATED ALKYL GROUP, AND WHEREIN THE ALKYL GROUPS MAY ALSO BEAR HALOGEN SUBSTITUTION BY REACTING A COMPOUND II

    2,4-DI(NH2-),5-((3,5-DI(CH3-O-),4-HO-PHENYL)-CH2-)-

    PYRIMIDINE

    WITH AN ALKYL HALIDE WHEREIN R IS DEFINED AS ABOVE. THE INVENTION ALSO COMPRISES COMPOUNDS OF FORMULA (I) WHEREIN R'' IS SELECTED FROM THE CLASS CONSISTING OF AN ALKYL GROUP HAVING A HALOGEN SUBSTITUTION AND AN UNSATURATED ALKYL GROUP. ADDITIONALLY, THE TERM R IN THE FORMULAS ABOVE MAY BE AN ARALKYL GROUP OR AN ALKYL OR ALKOXY SUBSTITUTED ARALKYL GROUP.

    4-((carboxyalkyl)amino)-5-pyrimidine-carboxylic acid esters
    10.
    发明授权
    4-((carboxyalkyl)amino)-5-pyrimidine-carboxylic acid esters 失效
    4 - ((羧甲基)氨基)-5-吡啶基 - 羧酸酯

    公开(公告)号:US3703517A

    公开(公告)日:1972-11-21

    申请号:US3703517D

    申请日:1971-05-14

    CPC classification number: C07D239/42

    Abstract: THE DISCLOSURE IS DIRECTED TO 5 - HYDROXY - 7H-PYRROLO (2,3-D)PYRIMIDINE-6-CARBOXYLIC ACID ESTERS AND TO 4-((CARBOXYALKYL)AMINO)-5-PYRIMIDINECARBOXYLIC ACID ESTERS. ALL THESE COMPOUNDS HAVE CENTRAL NERVOUS SYSTEM ACITIVITY AS DEPRESSANTS WHILE THE LATTER COMPOUNDS MAY ALSO BE USED IN THE PREPARATION OF THE FORMER COMPOUNDS.

Patent Agency Ranking